ImmunityBio is a brand dedicated to conquering cancer through the development of innovative therapies. Their mission is to create treatments that target disease without compromising the immune system. ImmunityBio focuses on investigational immunotherapy and cell therapy products, aiming to strengthen each patient's natural immune system to eliminate cancerous or infected cells.

They offer a range of therapies for various types of cancer, including bladder cancer, glioblastoma, non-small cell lung cancer, and pancreatic cancer, as well as diseases like HIV and COVID-19. ImmunityBio is committed to increasing diversity in clinical trials to reduce healthcare disparities. They also provide tools and solutions for trial investigators and research scientists to advance cancer research.

With a strong pipeline and a dedication to outsmarting diseases, ImmunityBio is shaping the future of cancer treatment